Search

everythinglearnresearchcommunity

for

Search:↓

A woman's hair loss was initially mistaken for a common hair loss condition but was later found to be caused by breast cancer cells in her scalp.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Vitamin D is important for skin health and can affect various skin diseases.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The document explains the diagnosis and characteristics of woolly hair nevus and alopecia neoplastica.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Cetuximab can cause excessive eyelash growth.

Infliximab improved skin and bowel symptoms in Crohn's disease but caused side effects and the disease returned after stopping treatment.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Radiation therapy for cancer often causes skin problems like redness, dryness, and pain.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Cetuximab can cause eyelash growth, which is rare but manageable.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

A cancer patient's hair became permanently curly after treatment with nivolumab.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Cetuximab can cause unusual hair growth and hair loss.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

PLD is an effective and safer alternative for treating breast cancer.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

A woman got melanoma on her scalp after anti-hair loss treatment with injections.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.